Our priorities

No Patient Left Behind is dedicated to ensuring all Americans have access to affordable and innovative health care. We do not need to choose between biopharmaceutical innovation and affordability. We can have both.

We believe this can be achieved by:

Enacting insurance reforms that eliminate or reduce patient out-of-pocket costs
Making sure all drugs go generic without undue delay
Preserving biopharmaceutical innovation incentives
Valuing new medicines based on their cost-effectiveness to society

Lowering patient out-of-pocket costs

Key Insurance reforms to help patients

Preserving innovation

How Price Controls Will Kill Innovation

All drugs should go generic

The case for contractual genericization

Did you know?

Increasing out-of-pocket costs by just $10 per prescription causes a 33% rise in mortality because fewer patients take the drugs their doctors prescribe.

Source: National Bureau of Economic Research, https://www.nber.org/papers/w28439 Get involved